PSIAC

Literaturverzeichnis


Raedler et al. (2004) Eur Psychiatry 19:366-369 [2183]
Raghavan N. Drug Metab Dispos. Jan 2009; 37(1): 74-81 Pubmed [266]
Ragheb M. J Clin Psychiatry. Apr 1987; 48(4): 161-3 Pubmed [1709]
Ragheb M. J Clin Psychiatry. Nov 1980; 41(11): 397-8 Pubmed [1710]
Ragheb M. J Clin Psychopharmacol. Oct 1990; 10(5): 350-4 Pubmed [1711]
Raghuthaman G. BJPsych Open. Dec 2015; 1(2): 172-177 Pubmed [4788]
Ragosta M. Am J Med. Apr 1989; 86(4): 465-6 Pubmed [6020]
Ragueneau-Majlessi I. Epilepsy Res. Nov 2001; 47(1-2): 55-63 Pubmed [1633]
Rahimi R. Expert Opin Drug Metab Toxicol. Jun 2012; 8(6): 691-708 Pubmed [3087]
Rahman A. Ann Pharmacother. May 2009; 43(5): 822-30 Pubmed [2823]
Rahman AP. Pharmacotherapy. Jul 2008; 28(7): 913-9 Pubmed [6317]
Rahn KH. N Engl J Med. Apr 1985; 312(14): 920-1 Pubmed [6173]
Rainey PM. J Acquir Immune Defic Syndr. Jul 2000; 24(3): 241-8 Pubmed [6720]
Raisch DW. Pharmacotherapy. Aug 2009; 29(8): 988-92 Pubmed [7070]
Raitasuo V, Lehtovaara R, Huttunen MO, Effect of switching carbamazepine to oxcarbazepine on the plasma levels of neuroleptics. A case report, Psychopharmacology (D) 116 (1), 115-116 (1994) [1989]
Raitasuo V. Am J Psychiatry. Jan 1993; 150(1): 169 Pubmed [1073]
Rajarethinam et al (2001) Schizophrenia Res 60:97-98 [1128]
Rajasingham R. HIV Med. Jul 2018; 19(6): e64-e65 Pubmed [6128]
Rajoli RKR. J Infect Dis. Dec 2018 Pubmed [6565]
Rakhit A. Eur J Clin Pharmacol. Jan 2008; 64(1): 31-41 Pubmed [4654]
Ramachandran G. J Acquir Immune Defic Syndr. May 2006; 42(1): 36-41 Pubmed [7139]
Ramachandran V. Drug Metab Dispos. Oct 1999; 27(10): 1194-9 Pubmed [4390]
Ramamoorthy Y. Biochem Pharmacol. Jun 2002; 63(12): 2111-9 Pubmed [4376]
Ramanathan R. Clin Infect Dis. Dec 2008; 47(12): e97-9 Pubmed [6457]
Ramanathan S. Clin Pharmacokinet. Apr 2011; 50(4): 229-44 Pubmed [6957]
Ramanathan S. Clin Pharmacokinet. Jan 2016; 55(1): 33-45 Pubmed [7375]
Ramanathan S. J Acquir Immune Defic Syndr. Jul 2007; 45(3): 274-9 Pubmed [3571]
Ramanathan S. J Acquir Immune Defic Syndr. Sep 2013; 64(1): 45-50 Pubmed [6958]
Ramanathan S. J Clin Pharmacol. May 2006; 46(5): 559-66 Pubmed [7360]
Ramasubbu R. Ann Pharmacother. Apr 2002; 36(4): 634-40 Pubmed [4172]
Ramasubbu R. Ann Pharmacother. Jul 2004; 38(7-8): 1197-201 Pubmed [3405]
Rampton DS. Br Med J. Sep 1977; 2(6087): 607-8 Pubmed, Volltext [3171]
Ramsay RR. Br J Pharmacol. Nov 2007; 152(6): 946-51 Pubmed, Volltext, Nature [3232]
Ramsay S. Can Urol Assoc J. Jan 2017; 11(1-2Suppl1): S74-S79 Pubmed [6950]
Ramsbottom KA. Mol Immunol. Sep 2018; 101: 488-499 Pubmed [7261]
Ramsey TD. Ann Pharmacother. Apr 2013; 47(4): 543-60 Pubmed [2672]
Randinitis EJ et al. Drugs (1999) 58 (Suppl 2) 254-5 [2110]
Rang ST. Can J Anaesth. Aug 2008; 55(8): 521-5 Pubmed [3915]
Rankin GO. Adverse Drug React Acute Poisoning Rev. Jul 1989; 8(2): 73-88 Pubmed [5363]
Rao et al. Drug Invest (1992) 4, 416-21 [1272]
Rao KB. Ann Pharmacother. Jun 2004; 38(6): 982-5 Pubmed [6969]
Rao N. Clin Pharmacokinet. Jan 2007; 46(4): 281-90 Pubmed [2931]
Rao S. J Assoc Physicians India. Nov 1994; 42(11): 881-2 Pubmed [6118]
Rapamune (Sirolimus). Wyeth Laboratories. Summary of product characteristics, March 2001 [773]
Rapoport BL. Rev Recent Clin Trials. Jan 2017; 12(3): 193-201 Pubmed [7858]
Rasheed A. J Pak Med Assoc. Oct 1994; 44(10): 233-4 Pubmed [527]
Rasmussen BB. Eur J Clin Pharmacol. Nov 1998; 54(9-10): 735-40 Pubmed [1490]
Rasmussen BB. Ther Drug Monit. Feb 1997; 19(1): 56-62 Pubmed [4757]
Rasmussen et al. Br J Clin Pharmacol 1995;45:1211-14 [1006]
Rastogi R. Anesthesiology. Dec 2011; 115(6): 1291-8 Pubmed [3548]
Rasul CH. Trop Doct. Jan 2000; 30(1): 55-6 Pubmed [6864]
Rataisuo V, et al. Psychopharmacology (Berl) (1994) 116, 115-16 [1984]
Rating The Delirogenic Potential of Drugs for Prediction of Side Effects in Elderly Psychiatric Inpatients. http://www.jacobspublishers.com/images/Pharmacology/J_J_Pharma_Pharmacovigilance_1_1_003.pdf [4]
Ratna P. Transplantation. Mar 2011; 91(6): e36-8 Pubmed [5229]
Rätz AE. Praxis (Bern 1994). May 2001; 90(19): 843-9 Pubmed [7168]
Rätz Bravo AE. Acta Oncol. Jan 2009; 48(4): 631-3 Pubmed [6971]
Rätz et al. (2004) Ann Pharmacother 38:1189-1193 [2892]
Rauch, Jenicke. Psychosomatics (1984) 25, 334-335 [2380]
Raucy JL. J Pharmacol Exp Ther. Aug 2002; 302(2): 475-82 Pubmed [4492]
Raungrut P. J Pharmacol Exp Ther. Aug 2010; 334(2): 609-18 Pubmed [3327]
Rauschenbach R. Environ Toxicol Pharmacol. Feb 1997; 3(1): 31-9 Pubmed [148]
Rauschenbach R. Eur J Pharmacol. Oct 1995; 293(3): 183-90 Pubmed [149]
Ravin DS. Ann Pharmacother. Jul 1997; 31(7-8): 867-70 Pubmed [5066]
Ravindran LN. J Clin Psychopharmacol. Feb 2008; 28(1): 107-8 Pubmed [2682]
Rawden HC. Br J Clin Pharmacol. Apr 2000; 49(4): 313-22 Pubmed, Volltext, DOI [286]
Ray AS. Antivir Ther. Jan 2005; 10(3): 451-7 Pubmed [7303]
Rayner CR. J Clin Pharmacol. Aug 2008; 48(8): 935-47 Pubmed [7067]
Read JS. J Int Assoc Physicians AIDS Care (Chic). Jun 2007; 6(2): 125-36 Pubmed [7104]
Recker MW. Ann Pharmacother. Sep 1997; 31(9): 996-8 Pubmed [6988]
Redaelli S. J Hematol Oncol. Jul 2015; 8: 81 Pubmed, Volltext, DOI [324]
Reddy S. Clin Kidney J. Jun 2018; 11(3): 429-433 Pubmed [6590]
Redington K, et al., ANN Inter Med (1992) 116,877-8 [2430]
Reductil (Sibutramine). Knoll Limited, UK. Summary of Product Characteristics, May 2001 [772]
Reed M. Ann Pharmacother. Feb 2005; 39(2): 357-60 Pubmed [6546]
Reed VA. CNS Drugs. Jul 2016; 30(7): 603-28 Pubmed [4877]
Rees CA. Cancer Chemother Pharmacol. Jan 1984; 12(2): 87-9 Pubmed [5578]
Reese J. Psychiatr Genet. Aug 2010; 20(4): 140-52 Pubmed [5569]
Reese MJ. Drug Metab Dispos. Feb 2013; 41(2): 353-61 Pubmed [4572]
Reese MJ. Drug Metab Dispos. Jul 2008; 36(7): 1198-201 Pubmed [1219]
Reeves PR. Xenobiotica. May 1978; 8(5): 313-20 Pubmed [46]
Regan AG,Aldrete JA. Prolonged apnea after administration of promazin hydrochloride following succinylcholin infusion. Anest Analg (1967) 46, 315-18 [2195]
Regazzi MB. J Antimicrob Chemother. Mar 2000; 45(3): 343-7 Pubmed [6318]
Reggiani et al. Acta Pharmacol Toxicol (1979) 45, 256 [789]
Reichert C. Clin Toxicol (Phila). Jul 2014; 52(6): 629-34 Pubmed [2240]
REID AA. Med J Aust. Feb 1964; 1: 187-8 Pubmed [830]
Reid J. Practitioner. Jul 1980; 224(1345): 751-3 Pubmed [532]
Reid JM. Clin Cancer Res. Aug 1999; 5(8): 2192-7 Pubmed [4445]
Reier CE, Johnstone RE. Anest Anal (1979) 49, 119-124 [2067]
Reilly CA. Chem Res Toxicol. Mar 2003; 16(3): 336-49 Pubmed [271]
Reilly PA. J Am Coll Cardiol. Feb 2014; 63(4): 321-8 Pubmed [3633]
Reimann IW. Clin Pharmacol Ther. Sep 1981; 30(3): 348-52 Pubmed [1686]
Reimann IW. Eur J Clin Pharmacol. Jan 1985; 29(4): 435-41 Pubmed [1752]
Reimer DR. J Fla Med Assoc. Jul 1974; 61(7): 573-4 Pubmed [657]
Reimers A. Epilepsia. Sep 2005; 46(9): 1414-7 Pubmed [1608]
Reimers A. J Clin Psychopharmacol. Aug 2005; 25(4): 342-8 Pubmed [2646]
Reis M, Lundmark J, Björk H, Bengtsson F. Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting. Ther Drug Monit. 2002 Aug;24(4):545-53 [2721]
Reis M. J Clin Psychopharmacol. Aug 2002; 22(4): 406-13 Pubmed [5078]
Reis M. Ther Drug Monit. Dec 2007; 29(6): 758-66 Pubmed [5079]
Reisz G. Am Rev Respir Dis. May 1983; 127(5): 581-4 Pubmed [5983]
Relkin NR. Dement Geriatr Cogn Disord. Jan 2003; 16(1): 15-24 Pubmed [3487]